SIREN CARE
Learn how health hardware startups go about proving clinical efficacy and market validation without access to serious cash.
THE CHALLENGE
How do direct-to-consumer healthcare hardware startups generate traction, validate the market, or prove clinical efficacy without the capital needed to manufacture and ship product?
-
Unfavorable unit-economics at small scale manufacturing / shipping
-
Tediously slow iteration / product development cycles
-
Not enough cash to run clinical trials, yet adoption suffers without clinical efficacy data
ABOUT THE COMPANY
Siren Care creates next generation smart textiles; their first product is a smart sock that helps people living with diabetes prevent amputations.
THE RESULTS
Won TechCrunch Hardware Battlefield
After months of marketing, PR, and pitch preparation, Siren Care presented and won at the 2017 TechCrunch Hardware Battlefield.
Clinical Studies Underway
Completing launch of a clinical trial that will further validate the clinical efficacy of Siren Care diabetic socks.
Investment and support from Tier-1 VCs
Backing of several Tier-1 VCs has not only extended the runway, but has enabled the deployment of capital upon growth activities that will futher accelerate Siren Care's traction.

Henk Jan Scholten
Co-Founder
"The mentors at 500 are phenomenal. They helped us untangle our B2B sales strategy and taught us how to run and grow a company."

Henk Jan Scholten
Co-Founder
"We benefited tremendously from the advise of folks at 500 who had already built successful companies. Their feedback helped us grow Siren Care while avoiding the common pitfalls of startups."